Caris Launches Cancer Registry to Provide Outcomes Data on Clinical Utility of Molecular Profiling

The Caris Registry will contain information about cancer patients using the company's Target Now suite of molecular profiling services, including the genetic profile of patients' tumors, their cancer treatment history, and their clinical outcome.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.